Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.42
+0.11 (2.07%)
At close: Dec 5, 2025, 4:00 PM EST
5.38
-0.04 (-0.74%)
After-hours: Dec 5, 2025, 4:04 PM EST
Bolt Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 5.2 | 7.69 | 7.88 | 5.73 | 1.26 | 0.23 | |
| Revenue Growth (YoY) | -46.88% | -2.36% | 37.48% | 354.68% | 445.46% | 7.44% | |
| Cost of Revenue | 35.27 | 57.47 | 61.54 | 73.12 | 75.66 | 40.36 | |
| Gross Profit | -30.07 | -49.78 | -53.67 | -67.39 | -74.4 | -40.13 | |
| Selling, General & Admin | 14.63 | 18.46 | 22.53 | 22.93 | 18.39 | 9.06 | |
| Operating Expenses | 14.63 | 18.46 | 22.53 | 22.93 | 18.39 | 9.06 | |
| Operating Income | -44.7 | -68.24 | -76.2 | -90.32 | -92.79 | -49.18 | |
| Interest & Investment Income | 3.11 | 5.26 | 7 | 2.22 | 0.28 | 0.2 | |
| Other Non Operating Income (Expenses) | 0.15 | - | - | - | -6.08 | -11.75 | |
| EBT Excluding Unusual Items | -41.43 | -62.98 | -69.2 | -88.1 | -98.59 | -60.73 | |
| Merger & Restructuring Charges | 0.22 | -3.34 | - | - | - | - | |
| Asset Writedown | -1.47 | -1.47 | - | - | - | - | |
| Other Unusual Items | - | 4.68 | - | - | - | - | |
| Pretax Income | -42.68 | -63.12 | -69.2 | -88.1 | -98.59 | -60.73 | |
| Net Income | -42.68 | -63.12 | -69.2 | -88.1 | -98.59 | -60.73 | |
| Net Income to Common | -42.68 | -63.12 | -69.2 | -88.1 | -98.59 | -60.73 | |
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 0 | |
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 0 | |
| Shares Change (YoY) | 0.64% | 0.98% | 1.21% | 12.54% | 1479.05% | 5.46% | |
| EPS (Basic) | -22.26 | -33.06 | -36.60 | -47.16 | -59.40 | -577.72 | |
| EPS (Diluted) | -22.26 | -33.06 | -36.60 | -47.16 | -59.40 | -577.72 | |
| Free Cash Flow | -47.2 | -61.33 | -69.73 | -78.46 | -59.4 | -50.57 | |
| Free Cash Flow Per Share | -24.62 | -32.12 | -36.88 | -42.00 | -35.79 | -481.09 | |
| Operating Margin | -860.38% | -887.33% | -967.45% | -1576.56% | -7364.13% | -21290.91% | |
| Profit Margin | -821.58% | -820.78% | -878.58% | -1537.75% | -7824.68% | -26289.18% | |
| Free Cash Flow Margin | -908.49% | -797.53% | -885.36% | -1369.47% | -4714.60% | -21891.78% | |
| EBITDA | -43.24 | -66.46 | -74.34 | -88.66 | -91.6 | -48.57 | |
| D&A For EBITDA | 1.46 | 1.78 | 1.85 | 1.67 | 1.19 | 0.61 | |
| EBIT | -44.7 | -68.24 | -76.2 | -90.32 | -92.79 | -49.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.